Advanced Search
MyIDEAS: Login to save this paper or follow this series

Il prezzo di riferimento nel quadro regolatorio del mercato farmaceutico

Contents:

Author Info

  • Chiara Bonassi

    (Autorità Garante della Concorrenza e del Mercato)

  • Laura Magazzini

    ()
    (Department of Economics, University of Verona)

  • Fabio Pammolli

    ()
    (IMT Lucca Institute for Advanced Studies and CERM Foundation - Competitività, Regole, Mercati)

  • Massimo Riccaboni

    ()
    (IMT Lucca Institute for Advanced Studies and and Department of Managerial Economics, Strategy and Innovation, K.U. Leuven)

  • Nicola Carmine Salerno

    ()
    (EIOPA - European Insurance and Occupational Pensions Authority)

Abstract

La letteratura suggerisce che l'applicazione del reference pricing avvenga solo sugli off-patent, sulla base di cluster chimico-terapeutico-biologici, con prezzo di rimborso allineato a quello del prodotto più economico. Non mancano, tuttavia, segnalazioni di criticità, riconducibili alle caratteristiche del contesto istituzionale e regolatorio. Tra queste, anche l’assenza di copayment percentuale sugli in-patent e sugli off-patent con prezzo allineato a quello di rimborso, nonché l'assenza di regole di pricing (in ammissione in fascia "A") e di governance annuale della spesa coerenti con la tipologia (innovazione significativa/incrementale, copia) e il "ciclo di vita" dei farmaci. Per quanto riguarda l'Italia, i dati sulle dinamiche di prezzo e sugli ingressi di nuovi produttori/prodotti sul mercato, nonché le recenti scoordinate sovrapposizioni Stato-Regioni nella gestione dello strumento, offrono una visione "luci ed ombre" dell'applicazione del reference pricing. L'attenzione va quegli snodi critici che più volte sono stati segnalati nel corso dei lavori del CERM e che questo Quaderno è occasione per ribadire.

Download Info

If you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
File URL: http://www.cermlab.it/wp-content/uploads/cerm/wp/wpcerm-2007-04.pdf
File Function: First version, 2007
Download Restriction: no

Bibliographic Info

Paper provided by Competitività Regole Mecati (CERM) in its series Working Papers with number 04-2007.

as in new window
Length: 60 pages
Date of creation: Dec 2007
Date of revision:
Handle: RePEc:ern:wpaper:04-2007

Contact details of provider:
Postal: Via Fiorentina, 1, 53100 Siena
Phone: +39 3488120691
Email:
Web page: http://www.cermlab.it/
More information through EDIRC

Related research

Keywords: mercato farmeceutico; reference pricing;

Find related papers by JEL classification:

References

References listed on IDEAS
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
as in new window
  1. Patricia M. Danzon & Jonathan D. Ketcham, 2003. "Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands and New Zealand," NBER Working Papers 10007, National Bureau of Economic Research, Inc.
  2. Lopez-Casasnovas, Guillem & Puig-Junoy, Jaume, 2000. "Review of the literature on reference pricing," Health Policy, Elsevier, Elsevier, vol. 54(2), pages 87-123, November.
  3. Paul V. Grootendorst & Lisa R. Dolovich & Anne M. Holbrook & Adrian R. Levy & Bernie J. O'Brien, 2002. "The Impact of Reference Pricing of Cardiovascular Drugs on Health Care Costs and Health Outcomes: Evidence from British Columbia -- Volume I: Summary," Quantitative Studies in Economics and Population Research Reports, McMaster University 369, McMaster University.
  4. Zweifel, Peter & Crivelli, Luca, 1996. "Price Regulation of Drugs: Lessons from Germany," Journal of Regulatory Economics, Springer, Springer, vol. 10(3), pages 257-73, November.
  5. Brekke, Kurt R. & Konigbauer, Ingrid & Straume, Odd Rune, 2007. "Reference pricing of pharmaceuticals," Journal of Health Economics, Elsevier, Elsevier, vol. 26(3), pages 613-642, May.
  6. Puig-Junoy, Jaume, 2004. "Incentives and pharmaceutical reimbursement reforms in Spain," Health Policy, Elsevier, Elsevier, vol. 67(2), pages 149-165, February.
  7. Ghislandi, Simone & Krulichova, Iva & Garattini, Livio, 2005. "Pharmaceutical policy in Italy: towards a structural change?," Health Policy, Elsevier, Elsevier, vol. 72(1), pages 53-63, April.
  8. Nina Pavcnik, 2002. "Do Pharmaceutical Prices Respond to Potential Patient Out-of-Pocket Expenses?," RAND Journal of Economics, The RAND Corporation, vol. 33(3), pages 469-487, Autumn.
  9. Thomas Aronsson & Mats Bergman & Niklas Rudholm, 2001. "The Impact of Generic Drug Competition on Brand Name Market Shares – Evidence from Micro Data," Review of Industrial Organization, Springer, Springer, vol. 19(4), pages 423-433, December.
  10. Lisa L. Ioannides-Demos & Joseph E. Ibrahim & John J. McNeil, 2002. "Reference-Based Pricing Schemes: Effect on Pharmaceutical Expenditure, Resource Utilisation and Health Outcomes," PharmacoEconomics, Springer Healthcare | Adis, Springer Healthcare | Adis, vol. 20(9), pages 577-591.
  11. Giuliani, Giovanni & Selke, Gisbert & Garattini, Livio, 1998. "The German experience in reference pricing," Health Policy, Elsevier, Elsevier, vol. 44(1), pages 73-85, April.
  12. Desmond Sheridan & Jim Attridge, 2006. "The Impact of Therapeutic Reference Pricing on Innovation in Cardiovascular Medicine," PharmacoEconomics, Springer, Springer, vol. 24(2), pages 35-54, December.
  13. Danzon, Patricia M & Chao, Li-Wei, 2000. "Does Regulation Drive out Competition in Pharmaceutical Markets?," Journal of Law and Economics, University of Chicago Press, University of Chicago Press, vol. 43(2), pages 311-57, October.
Full references (including those not matched with items on IDEAS)

Citations

Lists

This item is not listed on Wikipedia, on a reading list or among the top items on IDEAS.

Statistics

Access and download statistics

Corrections

When requesting a correction, please mention this item's handle: RePEc:ern:wpaper:04-2007. See general information about how to correct material in RePEc.

For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: ().

If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

If references are entirely missing, you can add them using this form.

If the full references list an item that is present in RePEc, but the system did not link to it, you can help with this form.

If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your profile, as there may be some citations waiting for confirmation.

Please note that corrections may take a couple of weeks to filter through the various RePEc services.